Clopidogrel (Plavix) will compete with prasugrel (Effient)
April 2008
Clopidogrel (Plavix) will compete with prasugrel (Effient) if it's approved...as early as this summer.
They're both in the same class...thienopyridines.
Prasugrel seems to be more effective than clopidogrel...for reducing cardiovascular events in some acute coronary syndrome patients undergoing angioplasty.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote